tiprankstipranks
Tourmaline Bio provides updates on TRANQUILITY trial, SAB
PremiumThe FlyTourmaline Bio provides updates on TRANQUILITY trial, SAB
2M ago
Tourmaline Bio to host investor day
Premium
The Fly
Tourmaline Bio to host investor day
3M ago
Tourmaline Bio initiated with an Outperform at BMO Capital
Premium
The Fly
Tourmaline Bio initiated with an Outperform at BMO Capital
3M ago
Keros Therapeutics appoints Chyung as CMO
PremiumThe FlyKeros Therapeutics appoints Chyung as CMO
4M ago
Tourmaline Bio initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Tourmaline Bio initiated with an Overweight at Cantor Fitzgerald
4M ago
Tourmaline Bio to host webinar on human genetic validation for IL-6 inhibition
Premium
The Fly
Tourmaline Bio to host webinar on human genetic validation for IL-6 inhibition
4M ago
Tourmaline Bio price target lowered to $15 from $18 at Truist
PremiumThe FlyTourmaline Bio price target lowered to $15 from $18 at Truist
6M ago
Tourmaline Bio reports Q2 EPS (68c), consensus (71c)
Premium
The Fly
Tourmaline Bio reports Q2 EPS (68c), consensus (71c)
7M ago
Tourmaline Bio management to meet with Piper Sandler
Premium
The Fly
Tourmaline Bio management to meet with Piper Sandler
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100